Just read the following article in today's paper:
QUOTE
Baxalta accepts US$ 32b bid from Shire
Dublin-based pharmaceutical group Shire has agreed to buy US peer Baxalta for US$ 32 billion in a deal aimed at forming a global biotech giant targeting rare diseases. The agreed cash-and-share offer was an improvement on a previous hostile bid of US$ 3o billion that Baxalta rejected in August. The purchase of the Illinois-based group will boost Shire's position in the market for rare-disease treatments in the pharmaceutical sector, which is undergoing a rapid consolidation.
"This proposed combination allows us to realise our vision of building the leading biotechnology company focused on rare diseases", Shire chief executive Flemming Ornskov said in a statement. "Our expanded portfolio and presence in more than 100 countries will drive our growth to over US$ 20 billion in anticipated annual revenues by 2020," he added.
AFP
END OF QUOTE
Makes - JIMHO - for happy reading to any holder of NEU.
wasa
this should be relevant to NEU's valuation, I would think...
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.97 |
Change
0.000(0.00%) |
Mkt cap ! $2.552B | |||
| Open | High | Low | Value | Volume |
| $19.96 | $19.97 | $19.69 | $4.156M | 209.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 246 | $19.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |